Back to search

Netherlands· NL-6a244ea529cd

Cluvot 1250 IE, poeder en oplosmiddel voor oplossing voor injectie of infusie

A coagulation factor xiii product containing factor xiii, registered in Netherlands by CSL Behring GmbH. The same ATC class is registered in 9 of our 19 countries.

ATC B02BD07

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedCluvot 1250 IE, poeder en oplosmiddel…ATCB02BD07REGISTER NO.NL-6a244ea529cdPACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Coagulation factor xiii is registered in 9 of 19 countries.

Countries holding a registration under ATC B02BD07 (coagulation factor xiii), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 6 of them publish a price we can compare per daily dose

Coagulation factor xiii · ATC B02BD07

9 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
FACTOR XIII
Manufacturer
CSL Behring GmbH
Country
Netherlands (NL)
ATC code
B02BD07
ATC class
Coagulation factor XIII
Defined daily dose
3.5 TSD, E
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    113097

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

2 interactions on record for coagulation factor xiii.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Coagulation factor xiii · interactions on record

2 records

  • 2 severe

Most severe, free to view

  • CarfilzomibL01XG02severe
  • CarfilzomibL01XX45severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/aac5f96a-8dd7-4513-b81e-e49d92820da1
GET /v1/drugs/aac5f96a-8dd7-4513-b81e-e49d92820da1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Poeder en oplosmiddel voor oplossing voor infusie, Poeder en oplosmiddel voor oplossing voor injectie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h113097_smpc.pdf",
  "strength": null,
  "atc_label": "Coagulation Factor XIII",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg113097",
  "excipients": [
    "GLUCOSE 1-WATER",
    "HUMAAN ALBUMINE",
    "NATRIUMCHLORIDE",
    "NATRIUMHYDROXIDE (E 524)",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "FACTOR XIII"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h113097.pdf",
  "authorised_at": "2014/03/25",
  "procedure_number": "DE/H/1942/002",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "113097",
  "additional_monitoring": "N"
}

See everything about coagulation factor xiii.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.